middle.news
How Noxopharm’s Sofra Platform Is Attracting Global Research Partnerships
9:05am on Thursday 30th of October, 2025 AEDT
•
Biotechnology
Read Story
How Noxopharm’s Sofra Platform Is Attracting Global Research Partnerships
9:05am on Thursday 30th of October, 2025 AEDT
Key Points
Multiple new collaborations exploring Sofra platform applications
HERACLES trial shows SOF-SKN is safe and well tolerated across dosing cohorts
US partner Tezcat Biosciences reports promising preclinical results
Convertible notes maturity extended to access $2.8 million R&D rebate
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
NOX
OPEN ARTICLE